A Comparison Between Sodium Alginate and Magaldrate Anhydrous in the Treatment of Patients with Gastroesophageal Reflux Symptoms
- 15 September 2006
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 51 (11) , 1904-1909
Abstract
The aims of the present study were to compare effects of sodium alginate and the antacid magaldrate anhydrous in adults with gastroesophageal reflux (GOR) symptoms. Patients with heartburn and/or acid regurgitation for at least 3 days in the week before the study started (n=203) were randomized to receive a single dose of sodium alginate or magaldrate anhydrous at the onset of symptoms during a 3-day run-in period. Patients with symptoms during the run-in (n=191) were rerandomized to receive a 14-day treatment with either drug given as four daily doses. A speed of action ≤30 min was significantly more frequent among patients in the alginate group (49.4% vs. 40.4%; P=0.0074). A trend toward a more prolonged duration of action (median: 16.5 vs. 12.7 hr) and a greater sum of the symptom intensity difference (median: 40.0 vs. 31.0) was observed in the sodium alginate group. Total disappearance of symptoms was reported in 81.6% and 73.9% of patients in the sodium alginate group and magaldrate group, respectively. We conclude that sodium alginate was faster than magaldrate in relieving GRO symptoms and showed a tendency toward a more prolonged duration of action and a higher level of efficacy.Keywords
This publication has 18 references indexed in Scilit:
- Outpatient Experience of Patients with GERD in the United States: Analysis of the 1998–2001 National Ambulatory Medical Care SurveyDigestive Diseases and Sciences, 2005
- Alginate rafts and their characterisationInternational Journal of Pharmaceutics, 2005
- An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH‐metryAlimentary Pharmacology & Therapeutics, 2004
- Sleep and gastroesophageal reflux disease: a wake-up call.2004
- Clinical Symptoms in Endoscopic Reflux Esophagitis: Evaluation in 8031 Adult SubjectsDigestive Diseases and Sciences, 2003
- The burden of illness of gastro‐oesophageal reflux disease: impact on work productivityAlimentary Pharmacology & Therapeutics, 2003
- Echo-planar magnetic resonance imaging of Gaviscon alginate rafts in-vivoJournal of Pharmacy and Pharmacology, 2002
- Respiratory Symptoms and Nocturnal Gastroesophageal RefluxChest, 2002
- Review article: alginate‐raft formulations in the treatment of heartburn and acid refluxAlimentary Pharmacology & Therapeutics, 2000
- In‐vivo anti‐reflux and raft properties of alginatesAlimentary Pharmacology & Therapeutics, 1990